Innoviva, Inc. [NASDAQ:INVA]: Analyst Rating and Earnings
Expert stock traders often make certain they pay attention what leading Wall Street analysts think regarding a potential stock purchase. As it relates to Innoviva, Inc. [INVA] currently, the latest ratings from Wall St. experts that can be seen publicly is related to the fiscal quarter that’s scheduled to end in December. On average, stock market experts give INVA an Outperform rating. Its stock price has been found in the range of 13.07 to 20.54. This is compared to its latest closing price of $14.71.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Innoviva, Inc. [INVA] is sitting at 2.50. This is compared to 1 month ago, when its average rating was 2.50.
For the quarter ending in Mar-19 Innoviva, Inc. [INVA] generated $0.06 billion in sales. That’s 1.25% higher than the average estimate of $0.05 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.
Pay attention to the next-scheduled financial results for this company to be released, which is slated for Thu 25 Jul (In 70 Days).
Fundamental Analysis of Innoviva, Inc. [INVA]
Now let’s turn to look at profitability: with a current Operating Margin for Innoviva, Inc. [INVA] sitting at +88.77.
This company’s Return on Total Capital is 54.30, and its Return on Invested Capital has reached 81.00%. Its Return on Assets is 86.30.
Turning to investigate this organization’s capital structure, Innoviva, Inc. [INVA] has generated a Total Debt to Total Equity ratio of 249.28. Similarly, its Total Debt to Total Capital is 71.37, while its Total Debt to Total Assets stands at 69.84. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 249.28, and its Long-Term Debt to Total Capital is 71.37. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.
What about valuation? This company’s Enterprise Value to EBITDA is 6.76 and its Total Debt to EBITDA Value is 1.48. The Enterprise Value to Sales for this firm is now 6.28, and its Total Debt to Enterprise Value stands at 0.17. Innoviva, Inc. [INVA] has a Price to Book Ratio of 11.49, a Price to Cash Flow Ratio of 8.85 and P/E Ratio of 4.16. These metrics all suggest that Innoviva, Inc. is more likely to generate a positive ROI.
Shifting the focus to workforce efficiency, Innoviva, Inc. [INVA] earns $45,804,500 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.57 and its Total Asset Turnover is 0.60. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 34.92 and its Current Ratio is 34.92. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Innoviva, Inc. [INVA] has 101.68M shares outstanding, amounting to a total market cap of $1.50B. Its stock price has been found in the range of 13.07 to 20.54. At its current price, it has moved by -27.65% from its 52-week high, and it has moved 13.70% from its 52-week low.
This stock’s Beta value is currently 1.72, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 59.65. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Innoviva, Inc. [INVA] a Reliable Buy?
Shares of Innoviva, Inc. [INVA], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.